search
Back to results

Comparing Erector Spinae Plane (ESP) and Transversus Abdominis Plane (TAP) Block in Inguinal Hernia (TAPESP)

Primary Purpose

Inguinal Hernia, Postoperative Pain, Anesthesia, Local

Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
ESP block
TAP block
Sponsored by
Ghielmini Enea
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Inguinal Hernia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Informed Consent as documented by signature
  • Patients over 18 years of age
  • Planned elective unilateral or bilateral robot-assisted TAPP hernia repair, with mesh placement

Exclusion Criteria:

  • Contraindications to ropivacaine or opioids, e.g. known hypersensitivity or allergy
  • Infections at the injection site
  • Coagulopathies or ongoing anticoagulant therapy
  • Concomitant surgery other than inguinal or umbilical hernia repair
  • Pre-operative chronic narcotic usage
  • Known chronic pain syndrome
  • Prior complex abdominal wall reconstruction
  • Frail patients for whom a prolonged sedation can be detrimental
  • Women who are pregnant
  • Known or suspected non-compliance, drug or alcohol abuse
  • Inability to consent or follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant

Sites / Locations

  • ORBV

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

real ESP, placebo TAP

real TAP, placebo ESP

Arm Description

US-guided ESP block + sham US-guided TAP block

sham US-guided ESP block + US-guided TAP block before laparoscopic hernia repair

Outcomes

Primary Outcome Measures

Highest Visual Analogue Scale
0 to 100mm, highest equals to more pain

Secondary Outcome Measures

Visual Analogue Scale score at rest and at movement
0 to 100mm, highest equals to more pain
Total dose of rescue opioids
(morphine equiavalents)
Time of first walk after surgery
Episodes of urinary retention
Need for anti-nausea medication (dosage, doses and time points)

Full Information

First Posted
February 9, 2021
Last Updated
August 11, 2022
Sponsor
Ghielmini Enea
search

1. Study Identification

Unique Protocol Identification Number
NCT04750512
Brief Title
Comparing Erector Spinae Plane (ESP) and Transversus Abdominis Plane (TAP) Block in Inguinal Hernia
Acronym
TAPESP
Official Title
Comparing Erector Spinae Plane (ESP) and Transversus Abdominis Plane (TAP) Block Analgesic Effect After Robotic TAPP Abdominal Hernia Repair: a Single Center, Randomized, Triple-blind, Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
January 11, 2021 (Actual)
Primary Completion Date
May 31, 2022 (Actual)
Study Completion Date
May 31, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Ghielmini Enea

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The Erectore Spinae Plane Block (ESP Block) is a recently described technique for regional anesthesia that has shown promising results in the treatment of pain after thoracic surgery. It involves the injection of local anesthetic behind the musculature of the back. The investigators intend to compare this technique with a more standardized one, the TAP Block, which involves injection of anesthetic behind the musculature of the abdomen. 50 patients undergoing robotic inguinal hernia repair under general anesthesia will be randomly selected to receive, in addition to general anesthesia, either the ESP block or the TAP block. Patients receiving an ESP Block will also receive an injection of saline solution in the TAP injection site, and the other way around. This will prevent preconceived ideas on either technique to influence the evaluationso of the effect. Pain scores and consumption of pain medication will be recorded during the 24 hours following the operation to compare the effect of the two techniques.
Detailed Description
In the recent era of increased awareness towards the risks and complications of opioid treatment, pain management after common surgical interventions by the means of regional anesthesia is of renewed interest for both clinical and logistic reasons, as it is known that good pain management reduces complications and cost associated to surgery. Regional and local anesthetic techniques after inguinal hernia surgery have been the topic of multiple studies, comparing various infiltrative methods, including wound infiltration, port site infiltration, iliohypogastric and ilioinguinal nerve block, paravertebral and transversus abdominis plane (TAP) block and epidural analgesia. Most methods investigate pain treatment in the setting of open surgery. The progressive evolution towards laparoscopic and robot-assisted methods changes the mechanisms of surgical pain and, with it, the rational for the choice of the analgesic technique adopted. The transversus abdominis plane (TAP) has become a widely used technique and has been demonstrated to be associated to a mild opioid sparing effect, but with inconsistent results. The erector spinae plane block is a promising technique, recently described and used especially in thoracic surgery. Multiple case reports and studies in pediatrics report it to be a safe and effective method for abdominal surgery as well, but no prospective randomized trials were published to date in the adult population, particularly with regard to laparoscopic or robotic hernia repair. A prospective comparison between the two techniques is therefore needed in this specific context. Hypothesis and primary objective: The investigators hypothesize the superiority of the ESP-block to the TAP-block with respect to post-operative pain control after abdominal surgery, leading to a reduction in reserve analgesic consumption. Our objective is to compare the clinical outcomes and safety of ESP block versus TAP block in patients undergoing robot-assisted TAPP inguinal hernia repair. Primary and secondary endpoints: Primary Endpoint: The highest VAS score reported between end of sedation and 6 hours after surgery or discharge of the patient, whichever comes first Secondary Endpoints Time to first rescue analgesic Total dose of rescue opioids (morphine equiavalents) in the first 24 hours after surgery Time of first walk after surgery Need for anti-nausea medication (dosage, doses and time points) Episodes of vomiting Episodes of urinary retention Patient's satisfaction (measured on the validated LPPS questionnaire for the perioperative patients' satisfaction ) Length of hospital stay Study design This is a single center, prospective, randomized, placebo-blinded, controlled superiority trial in 2 parallel arms comparing the efficacy and safety of the ESP Block and the TAP block on patients undergoing elective robot-assisted inguinal hernia repair. Follow up will consist in the hospitalization period plus one telephone consultation at 24 hours after hospitalization. Methods of minimizing bias: Randomisation - Patients will be randomized in a 1:1 ratio by a computer generated random number sequence through the RedCap software system. Blinding procedures According to the randomization arm patients will receive: sham US-guided ESP block + US-guided TAP block before laparoscopic hernia repair US-guided ESP block + sham US-guided TAP block before laparoscopic hernia repair Allocation will take place immediately before the intervention by the means of access to centralized, real-time allocation through a computer program. Personnel not directly involved with patient care will prepare a saline solution and a ropivacaine solution which will be allocated respectively to ESP or TAP block according to randomization. This will allow blinding of patients, care providers and data collectors. Analysis will be done on allocation-concealed data, permitting blinded analysis. Unbliding will be permitted if by doing so harm to one or more patients can be avoided or treated. After information of one of the principal investigators, specific patient allocation will be retrieved from the randomization program. Other methods of minimising bias Pain scores will be measured at 1, 3, 6, 12 and 24 hours after extubation and at the time of administration of reserve analgesics. The administration of reserve analgesics will follow a standardized internal protocol. Questionnaires validated to assess functional results after hernia surgery will be used for this study: pain: Visual Analogue Scale (VAS) surgical complications classification: Clavien Dindo's classification comorbidities : American Society of Anesthesiology (ASA) score validated LPPS questionnaire for the perioperative patients' satisfaction [21] EHS inguinal hernia classification

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inguinal Hernia, Postoperative Pain, Anesthesia, Local, Anesthesia Complication

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is a single center, prospective, randomized, "double-dummy" placebo-blinded, controlled superiority trial in 2 parallel arms comparing the efficacy and safety of the ESP Block and the TAP block on patients undergoing elective robot-assisted inguinal hernia repair.
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
According to the randomization arm patients will receive: sham US-guided ESP block + US-guided TAP block before laparoscopic hernia repair US-guided ESP block + sham US-guided TAP block before laparoscopic hernia repair Allocation will take place immediately before the intervention by the means of access to centralized, real-time allocation through a computer program. Personnel not directly involved with patient care will prepare a saline solution and a ropivacaine solution which will be allocated respectively to ESP or TAP block according to randomization. This will allow blinding of patients, care providers and data collectors. Analysis will be done on allocation-concealed data, permitting blinded analysis. Unbliding will be permitted if by doing so harm to one or more patients can be avoided or treated. After information of one of the principal investigators, specific patient allocation will be retrieved from the randomization program.
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
real ESP, placebo TAP
Arm Type
Experimental
Arm Description
US-guided ESP block + sham US-guided TAP block
Arm Title
real TAP, placebo ESP
Arm Type
Active Comparator
Arm Description
sham US-guided ESP block + US-guided TAP block before laparoscopic hernia repair
Intervention Type
Procedure
Intervention Name(s)
ESP block
Intervention Description
US guided ESP infiltration (saline solution vs Ropivacaine 0.2% according to randomization): bilateral injection of 30ml (60ml total) under US guidance between the deep fascia of erector spinae muscle and the the two transverse process at the level of the 10th thoracic vertebrae
Intervention Type
Procedure
Intervention Name(s)
TAP block
Intervention Description
US guided TAP block (saline solution vs Ropivacaine 0.2% according to randomization): bilateral injection of 30ml (total 60ml) under US guidance in the plane between the internal oblique and transversus abdominis muscles at the level of the midaxillary line in the Petit triangle.
Primary Outcome Measure Information:
Title
Highest Visual Analogue Scale
Description
0 to 100mm, highest equals to more pain
Time Frame
Between end of sedation and 6 hours after surgery
Secondary Outcome Measure Information:
Title
Visual Analogue Scale score at rest and at movement
Description
0 to 100mm, highest equals to more pain
Time Frame
1, 3, 6, 12 and 24 hours after surgery
Title
Total dose of rescue opioids
Description
(morphine equiavalents)
Time Frame
in the first 24 hours after surgery
Title
Time of first walk after surgery
Time Frame
24 hours
Title
Episodes of urinary retention
Time Frame
24 hours
Title
Need for anti-nausea medication (dosage, doses and time points)
Time Frame
24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Informed Consent as documented by signature Patients over 18 years of age Planned elective unilateral or bilateral robot-assisted TAPP hernia repair, with mesh placement Exclusion Criteria: Contraindications to ropivacaine or opioids, e.g. known hypersensitivity or allergy Infections at the injection site Coagulopathies or ongoing anticoagulant therapy Concomitant surgery other than inguinal or umbilical hernia repair Pre-operative chronic narcotic usage Known chronic pain syndrome Prior complex abdominal wall reconstruction Frail patients for whom a prolonged sedation can be detrimental Women who are pregnant Known or suspected non-compliance, drug or alcohol abuse Inability to consent or follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
Facility Information:
Facility Name
ORBV
City
Bellinzona
State/Province
Ticino
ZIP/Postal Code
6500
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Comparing Erector Spinae Plane (ESP) and Transversus Abdominis Plane (TAP) Block in Inguinal Hernia

We'll reach out to this number within 24 hrs